We provide you with 20 years of free, institutional-grade data for BEAM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BEAM. Explore the full financial landscape of BEAM stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$991,667
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| FMR LLC | Sale | -48,374 | $20.5 | $991,667 | 2025-08-01 |
| Simon Amy | Sale | -1,250 | $16.94 | $21,178 | 2025-07-03 |
| Simon Amy | Sale | -30,563 | $18.35 | $560,849 | 2025-04-03 |
| Bellon Christine | Sale | -5,674 | $18.35 | $104,122 | 2025-04-03 |
| Ciaramella Giuseppe | Sale | -7,434 | $18.35 | $136,418 | 2025-04-03 |
| Cavanagh Bethany J | Sale | -3,015 | $18.35 | $55,330 | 2025-04-03 |
| Evans John M. | Sale | -30,663 | $18.35 | $562,684 | 2025-04-03 |
| Bellon Christine | Grant, award...etc | 20,000 | 2025-04-02 | ||
| Simon Amy | Grant, award...etc | 27,500 | 2025-04-02 | ||
| Cavanagh Bethany J | Grant, award...etc | 10,000 | 2025-04-02 | ||
| Ciaramella Giuseppe | Grant, award...etc | 35,000 | 2025-04-02 | ||
| Evans John M. | Grant, award...etc | 77,500 | 2025-04-02 | ||
| Evans John M. | Derivatives Exercise | 30,000 | 2025-04-02 | ||
| Cavanagh Bethany J | Sale | -6,287 | $35 | $220,045 | 2025-02-20 |
| Bellon Christine | Sale | -10,000 | $34 | $340,000 | 2025-02-19 |
| Bellon Christine | Derivatives Exercise | 10,000 | 2025-02-19 | ||
| Evans John M. | Sale | -30,000 | $26.75 | $802,377 | 2025-02-03 |
| Bellon Christine | Sale | -1,241 | $24.68 | $30,628 | 2025-01-06 |
| Cavanagh Bethany J | Sale | -1,117 | $24.68 | $27,568 | 2025-01-06 |
| Emany Sravan Kumar | Grant, award...etc | 80,000 | 2025-01-02 | ||
| Ciaramella Giuseppe | Derivatives Exercise | 53,500 | 2024-12-19 | ||
| Ciaramella Giuseppe | Sale | -51,110 | $26.36 | $1,347,050 | 2024-11-08 |
| Ciaramella Giuseppe | Sale | -51,110 | $26.27 | $1,342,752 | 2024-10-16 |
| Ciaramella Giuseppe | Derivatives Exercise | 41,754 | 2024-10-16 | ||
| Cavanagh Bethany J | Sale | -289 | $23.48 | $6,785 | 2024-10-02 |
| Cavanagh Bethany J | Grant, award...etc | 2,500 | 2024-10-02 | ||
| Evans John M. | Sale | -60,000 | $24.6 | $1,476,024 | 2024-10-02 |
| Bellon Christine | Sale | -385 | $23.48 | $9,040 | 2024-10-02 |
| Cavanagh Bethany J | Initial | 2024-08-19 | |||
| Simon Amy | Sale | -1,250 | $23.76 | $29,700 | 2024-07-03 |
| Evans John M. | Sale | -60,000 | $24.5 | $1,470,156 | 2024-06-28 |
| Burrell Terry-Ann | Grant, award...etc | 12,500 | 2024-04-29 | ||
| Simon Amy | Sale | -23,687 | $32.13 | $761,063 | 2024-04-03 |
| Bellon Christine | Sale | -3,401 | $32.12 | $109,240 | 2024-04-03 |
| Burrell Terry-Ann | Sale | -5,446 | $32.12 | $174,926 | 2024-04-03 |
| Evans John M. | Sale | -18,102 | $32.13 | $581,617 | 2024-04-03 |
| Ciaramella Giuseppe | Sale | -4,534 | $32.12 | $145,632 | 2024-04-03 |
| Simon Amy | Grant, award...etc | 27,500 | 2024-04-02 | ||
| Burrell Terry-Ann | Grant, award...etc | 27,500 | 2024-04-02 | ||
| Bellon Christine | Grant, award...etc | 27,500 | 2024-04-02 | ||
| Ciaramella Giuseppe | Grant, award...etc | 35,000 | 2024-04-02 | ||
| Evans John M. | Grant, award...etc | 77,500 | 2024-04-01 | ||
| Evans John M. | Sale | -60,000 | $33.86 | $2,031,402 | 2024-04-01 |
| FMR LLC | Sale | -900,000 | $30.51 | $27,459,000 | 2024-02-15 |
| FMR LLC | Sale | -1,565 | $30.28 | $47,388 | 2024-02-15 |
| Evans John M. | Sale | -60,000 | $25.33 | $1,519,800 | 2024-02-02 |
| Bellon Christine | Sale | -1,907 | $26.42 | $50,383 | 2024-01-05 |
| Bellon Christine | Sale | -10,000 | $30 | $300,000 | 2023-11-22 |
| Bellon Christine | Derivatives Exercise | 10,000 | 2023-11-22 | ||
| Simon Amy | Sale | -3,448 | $18.7 | $64,478 | 2023-11-01 |
| Ciaramella Giuseppe | Derivatives Exercise | 90,900 | 2023-10-24 | ||
| Bellon Christine | Sale | -388 | $22.85 | $8,866 | 2023-10-04 |
| Simon Amy | Sale | -391 | $30.48 | $11,918 | 2023-08-09 |
| Ciaramella Giuseppe | Sale | -156,530 | $32.06 | $5,018,352 | 2023-07-25 |
| Ciaramella Giuseppe | Derivatives Exercise | 92,490 | 2023-07-25 | ||
| Burrell Terry-Ann | Sale | -4,640 | $30.31 | $140,638 | 2023-04-05 |
| Evans John M. | Sale | -11,654 | $30.31 | $353,233 | 2023-04-05 |
| Simon Amy | Sale | -16,099 | $30.31 | $487,961 | 2023-04-05 |
| Bellon Christine | Sale | -2,092 | $30.31 | $63,409 | 2023-04-05 |
| Ciaramella Giuseppe | Sale | -3,672 | $30.31 | $111,298 | 2023-04-05 |
| Burrell Terry-Ann | Grant, award...etc | 20,000 | 2023-03-31 | ||
| Evans John M. | Derivatives Exercise | 13,850 | 2023-03-31 | ||
| Evans John M. | Grant, award...etc | 56,250 | 2023-03-31 | ||
| Ciaramella Giuseppe | Grant, award...etc | 20,000 | 2023-03-31 | ||
| Bellon Christine | Grant, award...etc | 17,500 | 2023-03-31 | ||
| Bellon Christine | Derivatives Exercise | 8,941 | 2023-03-31 |
The information provided in this report about BEAM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Beam Therapeutics Inc(NASDAQ:BEAM) 
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease...
Website: http://www.beamtx.com
Founded: 2017
Full Time Employees: 166
CEO: John Evans
Sector: Healthcare
Industry: Biotechnology
